Altimmune Stock Analysis
ALT Stock | USD 4.08 0.03 0.74% |
Altimmune is undervalued with Real Value of 8.2 and Hype Value of 4.12. The main objective of Altimmune stock analysis is to determine its intrinsic value, which is an estimate of what Altimmune is worth, separate from its market price. There are two main types of Altimmune's stock analysis: fundamental analysis and technical analysis.
The Altimmune stock is traded in the USA on NASDAQ Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in the USA. Altimmune is usually not traded on Dr . Martin Luther King Jr 's Birthday, Washington 's Birthday, Good Friday, Memorial Day, Juneteenth Holiday, Independence Day, Labour Day, Thanksgiving Day, Christmas Day, New Year 's Day. Altimmune Stock trading window is adjusted to America/New York timezone.
Altimmune | Build AI portfolio with Altimmune Stock |
Altimmune Stock Analysis Notes
About 48.0% of the company shares are held by institutions such as insurance companies. The book value of Altimmune was presently reported as 1.83. The company recorded a loss per share of 1.26. Altimmune last dividend was issued on the 20th of January 2017. The entity had 1:30 split on the 14th of September 2018. Altimmune, Inc., a clinical stage biopharmaceutical company, focuses on developing treatments for obesity and liver diseases. Altimmune, Inc. was founded in 1997 is headquartered in Gaithersburg, Maryland. Altimmune operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 47 people. For more info on Altimmune please contact Vipin Garg at 240 654 1450 or go to https://altimmune.com.Altimmune Investment Alerts
Altimmune had very high historical volatility over the last 90 days | |
The company reported the last year's revenue of 20 K. Reported Net Loss for the year was (95.06 M) with loss before taxes, overhead, and interest of (76.55 M). | |
Altimmune has about 184.76 M in cash with (79.85 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 3.81. | |
Altimmune has a poor financial position based on the latest SEC disclosures |
Altimmune Upcoming and Recent Events
27th of February 2024 Upcoming Quarterly Report | View | |
9th of May 2024 Next Financial Report | View | |
31st of December 2023 Next Fiscal Quarter End | View | |
27th of February 2024 Next Fiscal Year End | View | |
30th of September 2023 Last Quarter Report | View | |
31st of December 2022 Last Financial Announcement | View |
Altimmune Market Capitalization
The company currently falls under 'Small-Cap' category with a total capitalization of 330.92 M.Technical Drivers
As of the 20th of July, Altimmune shows the Downside Deviation of 10.51, risk adjusted performance of 0.0343, and Mean Deviation of 4.66. Altimmune technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices.Altimmune Price Movement Analysis
The output start index for this execution was eleven with a total number of output elements of fifty. The Simple Moving Average indicator is calculated by adding the closing price of Altimmune for a given number of time periods and then dividing this total by the number of time periods. It is used to smooth out Altimmune short-term fluctuations and highlight longer-term trends or cycles.
Altimmune Insider Trading Activities
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Altimmune insiders, such as employees or executives, is commonly permitted as long as it does not rely on Altimmune's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Altimmune insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Altimmune Outstanding Bonds
Altimmune issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Altimmune uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Altimmune bonds can be classified according to their maturity, which is the date when Altimmune has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
Altice France 8125 Corp BondUS02156LAA98 | View | |
ALTICE FRANCE S Corp BondUS02156LAE11 | View | |
Altice France 55 Corp BondUS02156LAC54 | View | |
US02156LAH42 Corp BondUS02156LAH42 | View | |
US02156LAF85 Corp BondUS02156LAF85 | View | |
Altice Europe 5 Corp BondUS02154CAF05 | View | |
US02154CAH60 Corp BondUS02154CAH60 | View | |
MPLX LP 4125 Corp BondUS55336VAK61 | View |
Altimmune Predictive Daily Indicators
Altimmune intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Altimmune stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
Altimmune Forecast Models
Altimmune's time-series forecasting models are one of many Altimmune's stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Altimmune's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.About Altimmune Stock Analysis
Stock analysis is the technique used by a trader or investor to examine and evaluate how Altimmune prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Altimmune shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Altimmune. By using and applying Altimmune Stock analysis, traders can create a robust methodology for identifying Altimmune entry and exit points for their positions.
Altimmune, Inc., a clinical stage biopharmaceutical company, focuses on developing treatments for obesity and liver diseases. Altimmune, Inc. was founded in 1997 is headquartered in Gaithersburg, Maryland. Altimmune operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 47 people.
Be your own money manager
As an investor, your ultimate goal is to build wealth. Optimizing your investment portfolio is an essential element in this goal. Using our stock analysis tools, you can find out how much better you can do when adding Altimmune to your portfolios without increasing risk or reducing expected return.Did you try this?
Run Stock Tickers Now
Stock TickersUse high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites |
All Next | Launch Module |
Additional Tools for Altimmune Stock Analysis
When running Altimmune's price analysis, check to measure Altimmune's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Altimmune is operating at the current time. Most of Altimmune's value examination focuses on studying past and present price action to predict the probability of Altimmune's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Altimmune's price. Additionally, you may evaluate how the addition of Altimmune to your portfolios can decrease your overall portfolio volatility.